Advertisements


We are Sorry, This Page doesn't Exist


Ionis Pharmaceuticals, AstraZeneca advance new drug for NASH

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 9th, 2018

Ionic Pharmaceuticals shares jump 3% premarket on news of license deal with AstraZeneca

Ionis Pharmaceuticals Inc. shares rose 3% premarket Monday, after the company unveiled a licensing deal with AstraZeneca PlC for a treatment for nonalcoholic steatohepatitis (NASH), or fatty liver. Ionis said it will receive .....»»

Category: topSource: marketwatchApr 9th, 2018

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Agios Pharmaceuticals, Inc. (AGIO), initiates a phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with PK deficiency w.....»»

Category: dealsSource: nytJun 20th, 2018

Amag Pharmaceuticals upgraded to Buy after deal to sell CBR at B. Riley FBR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 15th, 2018

Sage shares drop 3% after $90 mln Shionogi deal for key drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 14th, 2018

Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer"s Drug Trials

Pharma giants AstraZeneca and Eli Lilly have scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder......»»

Category: smallbizSource: wsjJun 12th, 2018

Drugmaker revives female libido pill at half the price

Sprout Pharmaceuticals Inc. is relaunching Addyi, the first-ever approved drug for low libido in women -- and it’s slashing the drug’s price in half......»»

Category: topSource: moneycentralJun 11th, 2018

Drugmaker revives female libido pill at half the price

Sprout Pharmaceuticals Inc. is relaunching Addyi, the first-ever approved drug for low libido in women -- and it’s slashing the drug’s price in half......»»

Category: topSource: moneycentralJun 11th, 2018

Is an Acquisition in Portola Pharmaceuticals" Future?

The surprise departure of its long-time CEO and the recent approval of two new drugs have investors wondering if a deal is coming......»»

Category: topSource: foxnewsJun 5th, 2018

After 13 years and 2 drug approvals in past 12 months, Peninsula biotech CEO to leave

Bill Lis, who has led Portola Pharmaceuticals for eight years, will retire effective Aug. 1......»»

Category: topSource: bizjournalsJun 5th, 2018

After a $66 billion merger, one of the most hated food companies in the world is disappearing — sort of

Jim Young/Reuters German drug and chemical company Bayer is finalizing a $66 billion blockbuster deal to gobble up agricultural behemoth Monsanto on Thursday. On Monday, Bayer said it was dro.....»»

Category: topSource: businessinsiderJun 4th, 2018

Reata Pharmaceuticals announces orphan drug designation for bardoxolone methyl

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 31st, 2018

CRISPR, Vertex say FDA puts brakes on upcoming gene editing trial

Cambridge startup CRISPR Therapeutics and Boston-based Vertex Pharmaceuticals said on Wednesday that the FDA has put on hold a highly anticipated upcoming trial of their experimental gene editing drug for sickle cell disease. CRISPR (Nasdaq: CRIS.....»»

Category: topSource: bizjournalsMay 30th, 2018

Megyn Kelly Questioned If Starbucks Wants to ‘Deal With a Mass of Homeless People’ With New Store Policy

“For the paying customers who go in with their kids, do you really want to deal with a mass of homeless people or whoever is in there? Could be drug addicted—you don’t know when you’re there with your kids paying for the services of the place.”.....»»

Category: topSource: newsweekMay 29th, 2018

Megyn Kelly Questioned If Starbucks Wants to "Deal With a Mass of Homeless People" With New Store Policy

“For the paying customers who go in with their kids, do you really want to deal with a mass of homeless people or whoever is in there? Could be drug addicted—you don’t know when you’re there with your kids paying for the services of the place.”.....»»

Category: topSource: newsweekMay 29th, 2018

AstraZeneca"s drug extending survival rate in lung cancer patients

Using Imfinzi in stage III lung cancer, where cancer has only spread locally, opens up a multibillion-dollar sales opportunity.....»»

Category: topSource: business-standardMay 26th, 2018

Inovio Initiates Phase II Study on Pipeline Drug VGX-3100

Inovio (INO) begins a phase II study to evaluate the efficacy of its pipeline candidate VGX-3100 on adult men and women with human papilloma virus (HPV)-related anal dysplasia. Inovio Pharmaceuticals, INO has initiated a .....»»

Category: dealsSource: nytMay 22nd, 2018

Dova Receives FDA Nod For Bleeding Disorder Treatment; Rival Drug Awaits Clearance

Shares of Dova Pharmaceuticals Inc (NASDAQ: DOVA) trading was halted Monday morning in anticipation of a stock-sensitive announcement. read more.....»»

Category: blogSource: benzingaMay 21st, 2018

Dova Pharmaceuticals Slumps Despite FDA Approval

Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares dropped on Monday following a critical update from the U.S. Food and Drug Administration (FDA) on one of its subsidiaries. Essentially the agency........»»

Category: blogSource: 247wallstMay 21st, 2018

FDA approves Dova"s drug

The U.S. Food and Drug Administration has approved Durham-based Dova Pharmaceuticals' first drug. The approval is for avatrombopag, which treats low platelet count in patients with chronic liver disease. According to Dova, with about 70,000 patients with.....»»

Category: topSource: bizjournalsMay 21st, 2018